应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CPRX Catalyst Pharmaceutical Partners
交易中 05-01 14:40:27 EDT
15.34
+0.29
+1.93%
最高
15.40
最低
14.97
成交量
36.75万
今开
15.13
昨收
15.05
日振幅
2.82%
总市值
18.10亿
流通市值
15.61亿
总股本
1.18亿
成交额
559.83万
换手率
0.36%
流通股本
1.02亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Catalyst Pharmaceuticals, Inc.盘中异动 大幅拉升5.02%
自选股智能写手 · 03-28
Catalyst Pharmaceuticals, Inc.盘中异动 大幅拉升5.02%
嗡嗡声--美国股票走势-Voyager Therapeutics、GoodRx Holdings、Tenet Healthcare
Reuters · 02-29
嗡嗡声--美国股票走势-Voyager Therapeutics、GoodRx Holdings、Tenet Healthcare
加载更多
公司概况
公司名称:
Catalyst Pharmaceutical Partners
所属市场:
NASDAQ
上市日期:
--
主营业务:
Catalyst Pharmaceuticals, Inc.于2006年7月在特拉华州注册成立。该公司是一家商业阶段、以患者为中心的生物制药公司,专注于为患有罕见和难以治疗的疾病的患者提供新的高质量药物的许可、开发和商业化。该公司利用协调一致的勤奋努力,寻找能够改善那些患有罕见或难以治疗的疾病的人的生活的疗法。
发行价格:
--
{"stockData":{"symbol":"CPRX","market":"US","secType":"STK","nameCN":"Catalyst Pharmaceutical Partners","latestPrice":15.34,"timestamp":1714588824645,"preClose":15.05,"halted":0,"volume":367547,"delay":0,"floatShares":101783787,"shares":118011092,"eps":0.629999,"marketStatus":"交易中","marketStatusCode":2,"change":0.29,"latestTime":"05-01 14:40:27 EDT","open":15.13,"high":15.395,"low":14.97,"amount":5598285.514654,"amplitude":0.028239,"askPrice":15.36,"askSize":20,"bidPrice":15.34,"bidSize":107,"shortable":3,"etf":0,"ttmEps":0.629999,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1714593600000},"adr":0,"listingDate":1162962000000,"adjPreClose":15.05,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":15.11,"preClose":15.05,"latestTime":"09:29 EDT","volume":585,"amount":8811.849735,"timestamp":1714570199999},"postHourTrading":{"tag":"盘后","latestPrice":14.95,"preClose":15.05,"latestTime":"19:21 EDT","volume":239871,"amount":3609999.2572,"timestamp":1714519275077},"volumeRatio":0.493082},"requestUrl":"/m/hq/s/CPRX","defaultTab":"news","newsList":[{"id":"2422483959","title":"Catalyst Pharmaceuticals, Inc.盘中异动 大幅拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422483959","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422483959?lang=zh_cn&edition=full","pubTime":"2024-03-28 00:04","pubTimestamp":1711555442,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日00时04分,Catalyst Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.02%。Catalyst Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.19%。其相关个股中,Ibio, Inc.、Moolec Science Sa C/Wts 、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃,换手率分别为3178.86%、1187.69%、70.06%,振幅较大的相关个股有Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Stoke Therapeutics, Inc.,振幅分别为86.96%、78.00%、58.70%。Catalyst Pharmaceuticals, Inc.公司简介:Catalyst Pharmaceuticals Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328000403861e1b96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328000403861e1b96&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415547381","title":"嗡嗡声--美国股票走势-Voyager Therapeutics、GoodRx Holdings、Tenet Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2415547381","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2415547381?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:20","pubTimestamp":1709216448,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 2月29日 - 华尔街主要股指周四将高开,因为一项关键的通胀指标符合预期,从而提高了美国联邦储备委员会在今年上半年降息的希望。美东时间9:04,道指电子盘 上涨0.22%,报39,079点。标准普尔500指数小型股 上涨0.32%,报5097.25点;纳斯达克100指数小型股 上涨0.57%,报18016.75点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.catalystpharma.com","stockEarnings":[{"period":"1week","weight":0.0217},{"period":"1month","weight":-0.0558},{"period":"3month","weight":0.0451},{"period":"6month","weight":0.1926},{"period":"1year","weight":-0.1116},{"period":"ytd","weight":-0.1047}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":-0.0403},{"period":"3month","weight":0.0396},{"period":"6month","weight":0.1653},{"period":"1year","weight":0.2081},{"period":"ytd","weight":0.0561}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Catalyst Pharmaceuticals, Inc.于2006年7月在特拉华州注册成立。该公司是一家商业阶段、以患者为中心的生物制药公司,专注于为患有罕见和难以治疗的疾病的患者提供新的高质量药物的许可、开发和商业化。该公司利用协调一致的勤奋努力,寻找能够改善那些患有罕见或难以治疗的疾病的人的生活的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.053866},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.012194},{"month":3,"riseRate":0.666667,"avgChangeRate":0.104304},{"month":4,"riseRate":0.388889,"avgChangeRate":0.036621},{"month":5,"riseRate":0.529412,"avgChangeRate":-0.039012},{"month":6,"riseRate":0.588235,"avgChangeRate":0.053043},{"month":7,"riseRate":0.588235,"avgChangeRate":0.119007},{"month":8,"riseRate":0.647059,"avgChangeRate":0.238547},{"month":9,"riseRate":0.411765,"avgChangeRate":-0.027434},{"month":10,"riseRate":0.411765,"avgChangeRate":-0.064826},{"month":11,"riseRate":0.529412,"avgChangeRate":0.010396},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.030132}],"exchange":"NASDAQ","name":"Catalyst Pharmaceutical Partners","nameEN":"Catalyst Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Catalyst Pharmaceutical Partners(CPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Catalyst Pharmaceutical Partners(CPRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Catalyst Pharmaceutical Partners,CPRX,Catalyst Pharmaceutical Partners股票,Catalyst Pharmaceutical Partners股票老虎,Catalyst Pharmaceutical Partners股票老虎国际,Catalyst Pharmaceutical Partners行情,Catalyst Pharmaceutical Partners股票行情,Catalyst Pharmaceutical Partners股价,Catalyst Pharmaceutical Partners股市,Catalyst Pharmaceutical Partners股票价格,Catalyst Pharmaceutical Partners股票交易,Catalyst Pharmaceutical Partners股票购买,Catalyst Pharmaceutical Partners股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Catalyst Pharmaceutical Partners(CPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Catalyst Pharmaceutical Partners(CPRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}